To Peptide Nyatakaka dzi 
May 3, 2025
NYATAKAKAWO KPLE NUSIWO WOTSƆ ƑE NYATAKAKA SIWO KAtã WOÐO LE NYATAKAKADZRAÐOƑE SIA ME LA KPLE NYATAKAKAWO kaka KPLEE NUFIAFIA ƑE TAÐOÐOWO KO.
Wotrɔ asi le atike siwo wona le nyatakakadzraɖoƒe sia ŋu na numekuku le vitro ɖeɖeko. Wowɔa numekuku le vitro (Latingbe me: *le ahuhɔ̃e me*, si gɔmee nye le ahuhɔ̃e me) le amegbetɔ ƒe ŋutilã godo. Atike siawo menye atikewo o, United States ƒe Nuɖuɖu Kple Atike Ŋuti Dɔwɔƒe (FDA) meda asi ɖe wo dzi o, eye mele be woazã wo atsɔ axe mɔ ɖe atikewɔwɔ, dɔléle, alo dɔléle aɖeke nu, adae, alo adae o. Se de se vevie be woatsɔ atike siawo ade amegbetɔ alo lãwo ƒe ŋutilã me le mɔ ɖesiaɖe nu.
Peptide ƒe Nuwɔwɔ ƒe Gɔmesese Vevitɔ
Peptide ƒe wɔwɔme fia alesi wowɔa amino acid ƒe ɖoɖowo eye wowɔa amide kadodowo (si nye peptide kadodowo) to atike alo nugbagbeŋutinunya ƒe mɔnuwo dzi, si wɔnɛ be woate ŋu awɔ oligopeptide alo polypeptide molecule siwo si nugbagbeŋutinunya ƒe dɔwɔwɔ tɔxɛwo le la wɔwɔ le asinudɔwɔwɔ me koŋ. Abe nugbagbewo ƒe atikewɔwɔ ƒe alɔdze vevi aɖe ene la, mɔ̃ɖaŋununya sia léa ŋku ɖe amino acid monomers ƒe dɔwɔwɔ tiatiatɔe, mɔfiame ƒe ƒoƒo ɖekae, kple ɖoɖowɔwɔ ɖe wo nɔewo yome dzi kpɔkpɔ pɛpɛpɛ ŋu, eye wòxɔa nu bliboa tso miligram-dzidzenu nudokpɔƒe ƒe dzadzraɖo dzi va ɖo kilogram-dzidzeme dɔwɔƒewo wɔwɔ dzi. Wonɔ te ɖe nuwɔwɔ ƒe mɔnu vovovowo dzi dae ɖe hatsotsowo me ɖe nugbagbewo ƒe wɔwɔme mɔnu siwo nɔa te ɖe nugbagbewo ƒe ɖoɖowo kple atikewo wɔwɔ ƒe mɔnu siwo wotu ɖe nugbagbewo ƒe wɔwɔme ƒe gɔmeɖosewo dzi. Le esiawo dome la, solid-phase synthesis do abe mɔnu vevitɔ si wozãna tsɔ dzraa polypeptide atikewo kple numekuku-grade peptidewo ɖo le eƒe dɔwɔwɔ nyuie kple ŋutete si le esi be wòawɔ dɔ le eɖokui si ta. |
 |
Molekyulãwo ƒe Mɔnu si Wotsɔ Wɔa Peptide
Peptide kɔsɔkɔsɔwo ƒe atikewo ƒe wɔwɔme zɔna ɖe C-nuwuƒe vaseɖe N-nuwuƒe xɔtutu ƒe susuŋudɔwɔwɔ dzi. Tsɔ solid-phase synthesis abe kpɔɖeŋu ene: afɔɖeɖe veviawo bia be woatsɔ covalent abla amino acid si dze egɔme ƒe carboxyl ƒuƒoƒoa ɖe resin carrier si me mekɔ o ŋu gbã, axe mɔ ɖe axadzinuwɔnawo nu to N-nuwuƒe takpɔhawo dodo ɖe ŋgɔ me, woaɖe N-nuwuƒea ƒe takpɔkpɔ ɖa ɖe wo nɔewo yome, eye emegbe woatsɔe aƒo ƒu kple amino acid siwo wowɔ dɔ le eme be woawɔ peptide kadodo yeyewo. Dɔwɔwɔ sia bia be woakpɔ axadzikɔsɔkɔsɔ takpɔhawo ƒe nuwo ƒe sɔsɔme dzi pɛpɛpɛ be woaƒo asa na nuwɔna siwo menye tẽ o le ƒuƒoƒo siwo wɔa dɔ dome. Ne woƒo aŋɔa nu ƒu vɔ la, woɖea aŋɔa me le acid alo basic nɔnɔme sesẽwo me, eye woɖea axadzikɔsɔkɔsɔ takpɔhawo ɖa le ɣeyiɣi ɖeka me be woakpɔ peptide si womeɖa o la. To vovo na ema la, nugbagbewo ƒe wɔwɔme ƒe mɔa nɔa te ɖe ribosomal alo non-ribosomal synthetase ɖoɖowo dzi, si naa dzɔdzɔme peptidewo ƒe nugbagbewo ƒe wɔwɔme to mRNA template-mediated alo enzyme-catalytic domain assembly dzi. Viɖe si le eŋue nye ŋutete si le esi be wòawɔ peptide kɔsɔkɔsɔ siwo didi ŋutɔ kple dzɔdzɔmenu siwo ŋu wotrɔ asi le wòsesẽ ŋutɔ. |
 |
Mɔ̃ɖaŋununya Veviwo le Peptide Ƒe Dɔwɔnawo Me
Peptide ƒe wɔwɔme ƒe ɖoɖowo ƒe nyonyome nɔa te ɖe nuwɔna ƒe dɔwɔwɔ nyuie, nuteƒewɔwɔ le ɖoɖo nu, kple alesi woate ŋu atrɔ asi le eŋu ŋu. Le atikewo ƒe wɔwɔme me la, nu vevi siwo ana kadodo ƒe dɔwɔwɔ nanyo ɖe edzi eye woaɖe epimerization dzi akpɔtɔ dometɔ aɖewoe nye condensation reagents tiatia, solvent polarity ƒe tɔtrɔ, kple reaction ƒe dzoxɔxɔ dzi kpɔkpɔ pɛpɛpɛ. Be woakpɔ kuxi siwo bɔ ɖe ƒuƒoƒo me le peptide didi ƒe wɔwɔme me gbɔ la, woate ŋu ato kpekpeɖeŋunu siwo wotsɔna ƒoa ƒui abe HFIP ene vɛ, alo woazã segmental synthesis-ligation strategy. Kɔkɔenyenye nɔ te ɖe mɔnuwo abe reverse-phase high-performance liquid chromatography (RP-HPLC) kple gel filtration chromatography dzi, eye wokpɔa xɔtuɖoɖo ƒe kpeɖodzi to mass spectrometry (MS) kple nuclear magnetic resonance (NMR) dzi. Dzɔdzɔmeŋusẽdzikpɔkpɔ ƒe ɖoɖowo lɔ amino acidwo ƒe dzadzɛnyenye dodokpɔ le chiral, peptide ƒe agbɔsɔsɔme nyanya, kple ɖiƒoƒo ƒe nɔnɔme me dzodzro ɖe eme be woakpɔ egbɔ be atikewo ɖo atike alo numekuku ƒe dzidzenuwo gbɔ. Le biosynthetic dɔwɔwɔwo gome la, agbagbadzedze veviwo le mɔ̃ɖaŋununya ƒe tɔtrɔ le lãmenugbagbevi siwo xɔa dɔlékuiwo ŋu me, be woana peptide si woɖo taɖodzinu na ƒe ɖeɖefia kple eƒe ʋeʋẽ nanyo ɖe edzi to codon ƒe nyonyome kple secretion expression system tutu me, esime wole mɔ̃ɖaŋununya siwo nye downstream mama kple kɔklɔ ƒe mɔ̃ɖaŋununyawo ƒo ƒu ɖekae hena dɔwɔƒewo ƒe wɔwɔ.
Asixɔxɔ si le akpa vovovowo me kple Peptide siwo wowɔ kple wo zazã
Peptide siwo wowɔ wɔa akpa si womate ŋu aɖɔli o le nugbagbeŋutinunya, nuwo ŋuti dzɔdzɔmeŋutinunya, kple numekuku veviwo me. Le atikewɔnyawo gome la, atike siwo nye polypeptide—siwo ƒe dzesi enye be woƒe dɔwɔwɔ le tẽ ŋutɔ, aɖi mele wo me o, eye womegblẽa nu le nugbagbewo ŋu o—nye atike vevi siwo wozãna tsɔ daa dɔlélewo abe suklidɔ ene. Le antibody-drug conjugates (ADCs) me la, linker peptides xɔa dɔ vevitɔ si nye cytotoxic payloads ƒe taɖodzinu ɖoɖo ɖe amewo. Le nugbagbeŋutinunya me la, wozãa peptide siwo wowɔ abe antigen epitopes ene hena dɔlékuiwutikewo ƒe ŋgɔyiyi, abe ligandwo hena nusɔsrɔ̃ tso receptor-ligand ƒe kadodowo ŋu, alo abe enzyme substrates hena catalytic mechanisms ɖeɖeɖa. Le nuwo ŋuti dzɔdzɔmeŋutinunya me la, peptide siwo wɔa dɔ ate ŋu aƒo wo ɖokui nu ƒu azu nusiwo sɔ kple nugbagbewo abe nanofibers kple hydrogels ene, siwo wozãna le lãmenugbagbeviwo ƒe mɔ̃ɖaŋununya ƒe xɔtunuwo alo atikewo tsɔtsɔ yi na amewo ƒe mɔ̃wo me. Gakpe ɖe eŋu la, to atikewo ƒe tɔtrɔ alo amino acid siwo menye dzɔdzɔmenuwo o dede eme me la, peptide siwo wowɔ ate ŋu asrɔ̃ dzɔdzɔme proteinwo ƒe dɔwɔwɔ ƒe akpawo, si ana kpɔɖeŋu nyuiwo na nusɔsrɔ̃ tso protein ƒe wɔwɔme kple dɔwɔwɔ ƒe ƒomedodowo ŋu eye woado liƒowo ɖe ŋgɔ le atikewɔwɔ si sɔ pɛpɛpɛ kple atikewo ƒe nugbagbeŋutinunya me.
